Medical Cannabis for Acid Reflux (GERD) — Switzerland 2026

In PPI-refractory reflux, cannabinoids may help via CB1 receptors in the lower esophageal sphincter. Much cheaper for members.

20 % of Swiss suffer from chronic reflux; one third does not respond to PPIs. CB1 receptors regulate transient lower esophageal sphincter relaxations (TLESR) and visceral perception. Beaumont 2009: cannabinoid agonist reduced TLESR by 40 %. CannabisClub members: 50 CHF flat instead of 190.

What the studies show

Beaumont 2009: CB1 agonist reduced transient LES relaxations (TLESR) by 40 %.

Cohorts 2018–2023: cannabis users with functional dyspepsia/GERD report reduction in heartburn and visceral anxiety.

Preparations & dosing

CBD oil 25 mg twice daily — anti-inflammatory, viscero-protective.

THC 2.5 mg evenings for nocturnal reflux / pain-related sleep disturbance.

Save as a CannabisClub member

Gastroenterology cannabis consultations cost 190–250 CHF. Members: 50 CHF flat, telemedicine possible. Registration free.

FAQ

Does cannabis replace my PPI?

No. Add-on in PPI refractoriness. Discontinue PPI only with gastroenterologist.

What does membership save?

50 CHF instead of 190 CHF per consultation. Registration free.

Does insurance cover it?

Rarely — GERD is not a standard art. 71a indication. Usually out of pocket.

Cannabis for Acid Reflux (GERD) — Prescription Switzerland 2026 (Members 50 CHF)